WBIO.L vs. DOCT.L
Compare and contrast key facts about WisdomTree BioRevolution UCITS ETF USD Acc (WBIO.L) and L&G Healthcare Breakthrough UCITS ETF (DOCT.L).
WBIO.L and DOCT.L are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. WBIO.L is a passively managed fund by WisdomTree that tracks the performance of the NASDAQ Biotechnology TR USD. It was launched on Dec 3, 2021. DOCT.L is a passively managed fund by Legal & General that tracks the performance of the MSCI World/Health Care NR USD. It was launched on Jun 26, 2019. Both WBIO.L and DOCT.L are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Performance
WBIO.L vs. DOCT.L - Performance Comparison
Loading graphics...
WBIO.L vs. DOCT.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
WBIO.L WisdomTree BioRevolution UCITS ETF USD Acc | 6.20% | 13.58% | -14.08% | -5.86% | -18.74% | -1.39% |
DOCT.L L&G Healthcare Breakthrough UCITS ETF | -4.84% | 15.99% | 3.76% | -6.13% | -25.99% | -1.69% |
Different Trading Currencies
WBIO.L is traded in GBp, while DOCT.L is traded in USD. To make them comparable, the DOCT.L values have been converted to GBp using the latest available exchange rates.
Returns By Period
In the year-to-date period, WBIO.L achieves a 6.20% return, which is significantly higher than DOCT.L's -4.84% return.
WBIO.L
- 1D
- 2.24%
- 1M
- -1.78%
- YTD
- 6.20%
- 6M
- 13.76%
- 1Y
- 40.66%
- 3Y*
- 0.37%
- 5Y*
- —
- 10Y*
- —
DOCT.L
- 1D
- 3.30%
- 1M
- -3.77%
- YTD
- -4.84%
- 6M
- 9.72%
- 1Y
- 20.94%
- 3Y*
- 1.92%
- 5Y*
- -4.35%
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
WBIO.L vs. DOCT.L - Expense Ratio Comparison
WBIO.L has a 0.45% expense ratio, which is lower than DOCT.L's 0.49% expense ratio.
Return for Risk
WBIO.L vs. DOCT.L — Risk / Return Rank
WBIO.L
DOCT.L
WBIO.L vs. DOCT.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for WisdomTree BioRevolution UCITS ETF USD Acc (WBIO.L) and L&G Healthcare Breakthrough UCITS ETF (DOCT.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| WBIO.L | DOCT.L | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.39 | 0.97 | +0.43 |
Sortino ratioReturn per unit of downside risk | 1.95 | 1.47 | +0.48 |
Omega ratioGain probability vs. loss probability | 1.24 | 1.17 | +0.07 |
Calmar ratioReturn relative to maximum drawdown | 3.61 | 1.42 | +2.18 |
Martin ratioReturn relative to average drawdown | 8.49 | 4.46 | +4.03 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| WBIO.L | DOCT.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.39 | 0.97 | +0.43 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | -0.19 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.23 | 0.17 | -0.40 |
Correlation
The correlation between WBIO.L and DOCT.L is 0.81, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
WBIO.L vs. DOCT.L - Dividend Comparison
Neither WBIO.L nor DOCT.L has paid dividends to shareholders.
Drawdowns
WBIO.L vs. DOCT.L - Drawdown Comparison
The maximum WBIO.L drawdown since its inception was -51.13%, roughly equal to the maximum DOCT.L drawdown of -51.49%. Use the drawdown chart below to compare losses from any high point for WBIO.L and DOCT.L.
Loading graphics...
Drawdown Indicators
| WBIO.L | DOCT.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -51.13% | -57.55% | +6.42% |
Max Drawdown (1Y)Largest decline over 1 year | -11.52% | -17.02% | +5.50% |
Max Drawdown (5Y)Largest decline over 5 years | — | -55.82% | — |
Current DrawdownCurrent decline from peak | -21.86% | -34.50% | +12.64% |
Average DrawdownAverage peak-to-trough decline | -26.52% | -28.94% | +2.42% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.89% | 5.12% | -0.23% |
Volatility
WBIO.L vs. DOCT.L - Volatility Comparison
WisdomTree BioRevolution UCITS ETF USD Acc (WBIO.L) has a higher volatility of 7.91% compared to L&G Healthcare Breakthrough UCITS ETF (DOCT.L) at 7.33%. This indicates that WBIO.L's price experiences larger fluctuations and is considered to be riskier than DOCT.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| WBIO.L | DOCT.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.91% | 7.33% | +0.58% |
Volatility (6M)Calculated over the trailing 6-month period | 20.28% | 14.81% | +5.47% |
Volatility (1Y)Calculated over the trailing 1-year period | 29.02% | 21.62% | +7.40% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 23.78% | 22.74% | +1.04% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.78% | 23.67% | +0.11% |